|
COMMERCE BUSINESS DAILY ISSUE OF JANUARY 9,1997 PSA#1758EPA, ADP Placement Section (3803F), 401 M St. SW, Washington, DC
20460-0001 A -- EVALUATION OF EPIDEMIOLOGIC EVIDENCE FOR MAKING INFERENCES OF
CANCER HAZARDS AND RISKS FOR EXPOSURE TO TRICHLORETHYLENE SOL D7E401
DUE 012997 POC Melissa Revely-Brown WEB: NOT AVAILABLE,
http://www.epa.gov/oam/hpod. E-MAIL: CLICK HERE TO CONTACT THE
CONTRACTING OFFICER, revely-brown.melissa@epamail.epa.gov. The U.S.
Environmental Protection Agency (EPA) is issuing a request for proposal
for services to which the Government intends to award a firm fixed
price contract using the Simplified Acquisition Procedures of FAR Part
13. The EPA is FACNET certified. Any contractor/vendor able to meet
requirement must demonstrate in writing by closing date. All
responsible sources solicited may submit a bid, proposal, or quotation,
which shall be considered. This notice is intended for competitive
purposes. A determination by the Government not to compete this
proposed contract based upon responses to this notice is solely within
the discretion of the Government. Information received will normally
be considered solely for the purpose of determining whether to conduct
a competitive or negotiated procurement. The solicitation identifies
the office where additional technical information can be obtained and
you may E-mail the contracting officer at
revely-brown.melissa@epamail.epa.gov for a copy of the solicitation.
Please include the following: Company Name; Address; Phone Number;
Business Class; and Email Address. All requests for the solicitation
received by the closing date of this Notice will receive a copy of the
statement of work. (The 202/260-1225 number listed is a fax number.)
No phone calls accepted. All questions must be addressed in writing and
will be answered in writing to all interested parties. SUBJECT:
Evaluation of the Epidemiologic Evidence for Making Inferences of
Cancer Hazards and Risks for Exposure to Trichloroethylene Background
Trichloroethylene (TRI) is found in over 30% of Superfund sites,
including several Department of Energy and Department of Defense sites.
In the mid- 1980's, EPA evaluated the carcinogenicity of TRI (Health
Assessment Document for Trichloroethylene, EPA/600/8-82/006F, 1985;
Addendum, Draft, EPA/600/8-82-006FA, 1987). Risk-based standards and
cleanup decisions were based on the cancer slope factor developed in
the draft addendum and has been available on U.S. EPA's IRIS. The IRIS
entry, however, was withdrawn in 1989 pending resolution of the
classification as B2 (probably carcinogenic) or C (possibly
carcinogenic). Additionally, EPA does not have a position on
trichloroethylene's noncancer effects; an RfD and RfC have not been
developed. Within the past five years, new research has been published
on several aspects of trichloroethylene's toxicity. This research
includes epidemiologic studies of trichloroethylene-exposed
populations, pharmacokinetic models on trichloroethylene and it's
metabolites, and proposed modes of action for kidney, liver, and lung
toxicity/carcinogenicity. EPA's National Center for Environmental
Assessment has committed to examining the non-cancer and cancer effects
associated with trichloroethylene and its metabolites. With respect to
the human evidence, several epidemiologic studies of carcinogenic
effects and exposure to trichloroethylene in both the occupational
setting and from groundwater contamination (environmental studies) have
becomeavailable in the past several years. The International Agency for
Research on Cancer (IARC, 1995) considered this epidemiologic evidence
as "limited", leading to an overall classification for
trichloroethylene of "2B, probably carcinogenic to humans." The
American Council of Governmental Industrial Hygienists (ACGIH),
alternatively, evaluated the occupational epidemiologic data and
concluded that the evidence did not indicate a carcinogenic risk. ACGIH
classified occupational trichloroethylene exposure as "A5, not
carcinogenic to humans." The IARC evaluation is based upon a somewhat
larger data base than that used by ACGIH. Additionally, IARC used a
method to aggregate information across studies to support their
conclusion, whereas, ACGIH did not. For a copy of the statement of
work, please email your reques to revely-brown.melissa@epamail.epa.gov.
Please include the following: Company Name; Address; Phone Number;
Business Class; and Email Address. All requests for the solicitation
received by the closing date of this Notice will receive a copy of the
statement of work. (0007) Loren Data Corp. http://www.ld.com (SYN# 0002 19970109\A-0002.SOL)
A - Research and Development Index Page
|
|